Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kelly Nichols

Optometrist Birmingham, AL Doctor of Optometry

NPI 1558327817 CMS profile 1176252

1716 University Blvd, Hpb G080a, Birmingham, AL 35294

Open in the dashboard

General payments

$231,156

201 records reported · program years 2019–2025

Research payments

$750

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$66,565 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Kelly Nichols of Birmingham, AL is reported in the CMS Open Payments database as having received $231,156 across 201 general payments and $750 in research payments paid to them. Separately, studies naming them as principal investigator received $66,565 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $54,910 49
2024 General $40,407 47
2023 General $26,183 25
2022 General $12,989 13
2021 General $40,930 19
2020 General $48,172 26
2020 Research $750 1
2019 General $7,565 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kelly Nichols
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Kelly Nichols were reported at $54,910. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Kelly Nichols Optometrist median Middle half National median
2019 $7,565 $159 $67–$371 $163
2020 $48,172 $72 $29–$165 $114
2021 $40,930 $125 $46–$292 $132
2022 $12,989 $162 $66–$374 $149
2023 $26,183 $177 $72–$406 $160
2024 $40,407 $188 $77–$427 $164
2025 $54,910 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sight Sciences, Inc. $45,370 43 payments
  2. Alcon Research LLC $40,069 7 payments
  3. Kala Pharmaceuticals, Inc. $37,568 24 payments
  4. Bausch & Lomb Americas Inc. $22,317 26 payments
  5. AbbVie, Inc. $16,569 14 payments
  6. Dompe US, Inc. $15,844 16 payments
  7. Sun Pharmaceutical Industries Inc. $11,147 3 payments
  8. Topcon Medical Systems, Inc. $7,392 6 payments
  9. Tarsus Pharmaceuticals, Inc. $7,048 15 payments
  10. Alcon Vision LLC $6,558 7 payments
  11. Other $21,273 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $136,545 95 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $45,347 24 payments
  3. Royalty or License $26,319 1 payment
  4. Compensation for serving as faculty or as a speaker for a medical education program $9,375 5 payments
  5. Honoraria $5,032 5 payments
  6. Travel and Lodging $4,651 10 payments
  7. Food and Beverage $3,887 61 payments
Products named General payments · program years 2019–2025
  1. EYSUVIS $37,348 21 payments
  2. TEARCARE SYSTEM $33,919 26 payments
  3. Cequa $11,147 3 payments
  4. XIIDRA $7,864 8 payments
  5. TearCare $7,700 13 payments
  6. VUITY $3,998 3 payments
  7. TEARCARE(TM) (2.2) SYSTEM KIT $3,750 4 payments
  8. TearCare SmartLid $3,750 4 payments
  9. TYRVAYA $3,028 7 payments
  10. TearLab Osmolarity System $2,340 3 payments
  11. Other $14,539 35 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Novartis Pharma AG $750 1 payment

Records

202 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record